Primary Glossodynia Well-Treated with Triple-Drug Combination: A Case Series

DOI
  • Momota Yukihiro
    Department of Oral Medicine, Institute of Biomedical Sciences, Tokushima University Graduate Faculty of Dentistry Oral Health Management Center, Tokushima University Hospital
  • Takano Hideyuki
    Oral Health Management Center, Tokushima University Hospital
  • Kani Koichi
    Department of Oral Medicine, Institute of Biomedical Sciences, Tokushima University Graduate Faculty of Dentistry
  • Matsumoto Fumihiro
    Department of Oral Medicine, Institute of Biomedical Sciences, Tokushima University Graduate Faculty of Dentistry
  • Aota Keiko
    Department of Oral Medicine, Institute of Biomedical Sciences, Tokushima University Graduate Faculty of Dentistry
  • Yamanoi Tomoko
    Department of Oral Medicine, Institute of Biomedical Sciences, Tokushima University Graduate Faculty of Dentistry
  • Takase Nao
    Department of Oral Medicine, Institute of Biomedical Sciences, Tokushima University Graduate Faculty of Dentistry
  • Miyamoto Yuki
    Department of Oral Medicine, Institute of Biomedical Sciences, Tokushima University Graduate Faculty of Dentistry
  • Ono Shinji
    Oral Health Management Center, Tokushima University Hospital
  • Azuma Masayuki
    Department of Oral Medicine, Institute of Biomedical Sciences, Tokushima University Graduate Faculty of Dentistry Oral Health Management Center, Tokushima University Hospital

Bibliographic Information

Other Title
  • 三剤併用が奏効した一次性舌痛症の3例

Description

Primary glossodynia is characterized by abnormal sensations such as tongue pain without pathological changes and is not fully understood. Primary glossodynia is reported to be associated with neurophathic pain. We describe the cases of 3 patients（2 males, 1 female, mean age 54.3 years, range 42-79 years） with primary glossodynia that was treated with the concomitant medication of pregabalin （50-300mg/day）, tramadol hydrochloride/acetaminophen tablets （37.5/325-150/1,300mg/day）, and powdered processed aconite roots （0.5-1.5mg/day）. This medication remarkably relieved the patientsʼ primary glossodynia and promoted health-reated quality of life of them. Significant adverse events did not occur in any of the cases.<br>This concomitant medication may be useful for the treatment of primary glossodynia.

Journal

Keywords

Details 詳細情報について

  • CRID
    1390846609775857792
  • NII Article ID
    130007757187
  • DOI
    10.11264/jjop.11.21
  • ISSN
    18829333
    1883308X
  • Text Lang
    ja
  • Data Source
    • JaLC
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top